Literature DB >> 3337943

Growth rate of human tumour xenografts measured in nude mice by in vivo cast modelling.

A G Fiennes1.   

Abstract

Caliper measurement of xenograft tumour volume incurs shape-dependent errors of up to 230 per cent. A more sensitive and accurate method is described for repeated in vivo measurement of tumour volume by cast modelling. The technique can provide electronic data for further analysis and its accuracy and limitations can themselves be determined. Week-on-week changes in tumour volume may be detected with up to 99 per cent confidence.

Entities:  

Mesh:

Year:  1988        PMID: 3337943     DOI: 10.1002/bjs.1800750109

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  5 in total

1.  Automated measurement of transplantable solid tumors using digital electronic calipers interfaced to a microcomputer.

Authors:  J F Worzalla; J R Bewley; G B Grindey
Journal:  Invest New Drugs       Date:  1990-08       Impact factor: 3.850

2.  Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements.

Authors:  Gregory D Ayers; Eliot T McKinley; Ping Zhao; Jordan M Fritz; Rebecca E Metry; Brenton C Deal; Katrina M Adlerz; Robert J Coffey; H Charles Manning
Journal:  J Ultrasound Med       Date:  2010-06       Impact factor: 2.153

3.  William L. McGuire Memorial Symposium. 1,25(OH)2D3 modulation of mammary tumor cell growth in vitro and in vivo.

Authors:  S Saez; N Falette; C Guillot; F Meggouh; M F Lefebvre; M Crepin
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Reduced tumour growth of the human colonic cancer cell lines COLO-320 and HT-29 in vivo by dietary n-3 lipids.

Authors:  M Sakaguchi; S Rowley; N Kane; C Imray; A Davies; C Jones; M Newbold; M R Keighley; P Baker; J P Neoptolemos
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

5.  Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression.

Authors:  Anthony J Apostoli; Jennifer M Roche; Mark M Schneider; Sandip K SenGupta; Michael A Di Lena; Rachel E Rubino; Nichole T Peterson; Christopher J B Nicol
Journal:  Mol Cancer       Date:  2015-04-15       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.